0001140361-17-000180.txt : 20170103 0001140361-17-000180.hdr.sgml : 20170103 20170103174649 ACCESSION NUMBER: 0001140361-17-000180 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161229 FILED AS OF DATE: 20170103 DATE AS OF CHANGE: 20170103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BIENAIME JEAN JACQUES CENTRAL INDEX KEY: 0001221590 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 17502990 MAIL ADDRESS: STREET 1: 925 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 4 1 doc1.xml FORM 4 X0306 4 2016-12-29 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001221590 BIENAIME JEAN JACQUES C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901 1 1 0 0 Chief Executive Officer Common Stock 2016-12-29 2016-12-29 4 M 0 4000 17.33 A 174682 D Common Stock 2016-12-29 2016-12-29 4 S 0 4000 83.84 D 170682 D Common Stock 2016-12-30 2016-12-30 4 M 0 4000 17.33 A 174682 D Common Stock 2016-12-30 2016-12-30 4 S 0 4000 83.35 D 170682 D Common Stock 182801 I Shares held by Jean-Jacques Bienaime Family Trust Stock Option (right to buy Common Stock) 17.33 2016-12-29 2016-12-29 4 M 0 4000 0 D 2007-12-07 2017-06-06 Common Stock 4000 113423 D Stock Option (right to buy Common Stock) 17.33 2016-12-30 2016-12-30 4 M 0 4000 0 D 2007-12-07 2017-06-06 Common Stock 4000 109423 D Trade made pursuant to a 10b5-1 plan executed on November 15, 2016. All shares were sold at the same price. Reflects the number of stock options outstanding after the transaction from this specific stock option grant. /s/ Laura Randall Woodhead, Attorney-in-Fact 2017-01-03